-
19286-1A natural plant phenolic that shares features of coumarins and catechols inhibits lipoxygenases (LOs), including 5-LO and 12-LO (ID50s = 4 and 2.5 µM, respectively) used as an antioxidant to reduce reactive oxygen species and modulate
-
19286-10A natural plant phenolic that shares features of coumarins and catechols inhibits lipoxygenases (LOs), including 5-LO and 12-LO (ID50s = 4 and 2.5 µM, respectively) used as an antioxidant to reduce reactive oxygen species and modulate
-
19286-25A natural plant phenolic that shares features of coumarins and catechols inhibits lipoxygenases (LOs), including 5-LO and 12-LO (ID50s = 4 and 2.5 µM, respectively) used as an antioxidant to reduce reactive oxygen species and modulate
-
19286-5A natural plant phenolic that shares features of coumarins and catechols inhibits lipoxygenases (LOs), including 5-LO and 12-LO (ID50s = 4 and 2.5 µM, respectively) used as an antioxidant to reduce reactive oxygen species and modulate
-
19130-1A inhibitor of Epac1 and Epac2 (IC<sub>50</sub>s = 3.2 and 1.4 µM, respectively) blocks Akt phosphorylation and insulin secretion in pancreatic &beta cells and inhibits the migration of AsPC-1 and PANC-1 pancreatic cancer cells in vitro.
-
19130-10A inhibitor of Epac1 and Epac2 (IC<sub>50</sub>s = 3.2 and 1.4 µM, respectively) blocks Akt phosphorylation and insulin secretion in pancreatic &beta cells and inhibits the migration of AsPC-1 and PANC-1 pancreatic cancer cells in vitro.
-
19130-25A inhibitor of Epac1 and Epac2 (IC<sub>50</sub>s = 3.2 and 1.4 µM, respectively) blocks Akt phosphorylation and insulin secretion in pancreatic &beta cells and inhibits the migration of AsPC-1 and PANC-1 pancreatic cancer cells in vitro.
-
19130-5A inhibitor of Epac1 and Epac2 (IC<sub>50</sub>s = 3.2 and 1.4 µM, respectively) blocks Akt phosphorylation and insulin secretion in pancreatic &beta cells and inhibits the migration of AsPC-1 and PANC-1 pancreatic cancer cells in vitro.
-
17326-10The (S)-enantiomer of omeprazole, a selective inhibitor of the gastric H+/K+ ATPase that demonstrates increased bioavailability compared to omeprazole.
-
17326-25The (S)-enantiomer of omeprazole, a selective inhibitor of the gastric H+/K+ ATPase that demonstrates increased bioavailability compared to omeprazole.
-
17326-50The (S)-enantiomer of omeprazole, a selective inhibitor of the gastric H+/K+ ATPase that demonstrates increased bioavailability compared to omeprazole.
-
18232-1An estrogen steroid hormone exclusively produced by fetal liver from estradiol and estriol during pregnancy binds ER&alpha with 4-fold higher affinity for over ER&beta exhibits estrogenic effects in bone, brain, vagina, and endometrium acts as